Baseline Total Metabolic Tumour Volume Is Highly Prognostic for Refractoriness to Immunochemotherapy in Dlbcl: An Analysis of the Phase 3 Goya Trial
Hematological Oncology - United Kingdom
doi 10.1002/hon.20_2629
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley